The mechanosensitive channel TRPV4 inhibits pulmonary inflammation by limiting NF-κB signaling in alveolar macrophages
Science Signaling · 2025
DOI: 10.1126/scisignal.adt1539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Adam M Boulton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immunity, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: TRPV Cation Channels, Macrophages, Alveolar, Transcription Factor RelA, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The nuclear factor κB (NF-κB) signaling pathway plays a critical role in activating macrophages in the pathogenesis of many inflammatory diseases. Tissue mechanical properties are important in modulating key cellular proinflammatory responses. Here, we investigated how the mechanosensitive membrane cation channel TRPV4 (transient receptor potential vanilloid 4) limits macrophage proinflammatory responses in bacterial pneumonia. We found that TRPV4 suppressed proinflammatory gene expression in alveolar macrophages in response to Pseudomonas aeruginosa pneumonia in mice and in response to agonists of various Toll-like receptors (TLRs) in vitro. TRPV4 suppressed proinflammatory gene expression in macrophages by decreasing the activity of the NF-κB subunit p65. Upon stimulation of macrophages with bacterial lipopolysaccharide, a fraction of TRPV4 translocated from the endoplasmic reticulum to the plasma membrane, releasing p65 for nuclear translocation. TRPV4 interacted with p65 through an N-terminal cytoplasmic ankyrin repeat domain (ANKRD) that shares sequence homology with the p65-binding ANKRD of the NF-κB inhibitor IκBα. Given the diverse roles of TRPV4 and NF-κB in various cell types, our identification of cross-talk between a mechanosensitive channel and p65 in macrophages suggests application to many NF-κB–dependent diseases, such as cancer and atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Inflammation and Immunity, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.
- Integrated Hospital Care Institute, Department of Pulmonary and Critical Care, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.
- Neuroscience, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.
ORCID-Profile: Adam M Boulton, Megan E Grund, Erica M Orsini, Yan Liu, Susamma Abraham, Lisa M Grove, Ryan Musich, Amber Cardani-Boulton, Vidula Vachharajani, Mitchell A Olman, Rachel G Scheraga
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Boulton, A. M., Grund, M. E., Wang, Y., Orsini, E. M., Liu, Y., Abraham, S., Grove, L. M., Musich, R., Snyder, C. M., Ricci, H., Cardani-Boulton, A., Vachharajani, V., Olman, M. A., & Scheraga, R. G. (2025). The mechanosensitive channel TRPV4 inhibits pulmonary inflammation by limiting NF-κB signaling in alveolar macrophages. Science Signaling. https://doi.org/10.1126/scisignal.adt1539
Vancouver
Boulton AM, Grund ME, Wang Y, Orsini EM, Liu Y, Abraham S, et al. The mechanosensitive channel TRPV4 inhibits pulmonary inflammation by limiting NF-κB signaling in alveolar macrophages. Science Signaling. 2025. doi:10.1126/scisignal.adt1539
BibTeX
@article{Boulton2025,
author = {Boulton, Adam M and Grund, Megan E and Wang, Yuxin and Orsini, Erica M and Liu, Yan and Abraham, Susamma and Grove, Lisa M and Musich, Ryan and Snyder, Caitlin M and Ricci, Haley and Cardani-Boulton, Amber and Vachharajani, Vidula and Olman, Mitchell A and Scheraga, Rachel G},
title = {The mechanosensitive channel TRPV4 inhibits pulmonary inflammation by limiting NF-κB signaling in alveolar macrophages},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adt1539}
}
EUVIMED